Eric Halioua, President & CEO of PDC*line Pharma, was invited on BMF Business to speak about the new class of immunotherapies active against cancer which his team is developing. Watch the replay here: Contact us to get more information: Source: https://bfmbusiness.bfmtv.com/mediaplayer/video/eric-halioua-pdcline-pharma-pdcline-pharma-developpe-une-nouvelle-classe-d-immunotherapies-actives-contre-les-cancers-0205-1244108.html
Check the latest issue of Biotech Finances to read an interview of PDC*line Pharma’s President & CEO Eric Halioua describing the recent fund raising completed and the perspectives of the company. Read the full article: https://www.biotech-finances.com/126504-2/ Contact us to get more information:
A new article about our customer PDC*line Pharma published in the newspaper L’Echo: with an interview of President & CEO Eric Halioua underlining the achievements made by the company over the last 4 years. Source: https://www.lecho.be/entreprises/pharma-biotechnologie/PDC-line-Pharma-nouvel-espoir-wallon-contre-le-cancer/10191614